<DOC>
	<DOCNO>NCT02953093</DOCNO>
	<brief_summary>The investigator study effect acarbose muscle adipose gene transcription old adult .</brief_summary>
	<brief_title>Study Acarbose Longevity</brief_title>
	<detailed_description>Acarbose , FDA approve drug treatment type 2 diabetes , know effect glucose metabolism . Evidence mouse indicates acarbose may prolong lifespan . In human , acarbose improves inflammatory marker reduces cardiovascular event . Consequently , acarbose interest clinical translational age research since may influence fundamental process contribute age-related disease . The study describe herein exploratory study examine effect acarbose treatment biology age human . Specifically , investigator plan study whether treatment 10 week course acarbose alter gene expression profile adipose tissue muscle old adult pathway know affected human age , placebo-controlled crossover study .</detailed_description>
	<mesh_term>Acarbose</mesh_term>
	<criteria>Male age &gt; 60 year impair fast glucose ( IFG ) impair glucose tolerance ( IGT ) cancer heart failure COPD inflammatory condition eGFR &lt; 45 active liver disease poorly control hypertension epilepsy recent cardiovascular disease event ( last 6 month ) inflammatory bowel disease history bariatric gastric surgery cigarette smoke serious substance abuse . Treatment drug know influence glucose metabolism Hypersensitivity acarbose component formulation . Treatment anticoagulant medication antiplatelet drug</criteria>
	<gender>Male</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>acarbose</keyword>
	<keyword>age</keyword>
</DOC>